Is there a role for 5-HT1A agonists in the treatment of depression?

Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States

1994 • 12,456 citations

Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus

2000 • 3,047 citations

Current advances and trends in the treatment of depression

1994 • 1,111 citations

Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding

1980 • 840 citations

Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT_1A and 5‐HT_1B agonists

1987 • 838 citations

The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression

1997 • 823 citations

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

2001 • 818 citations

The National Depressive and Manic-Depressive Association Consensus Statement on the Undertreatment of Depression

1997 • 534 citations

Projections of the median raphe nucleus in the rat

1999 • 515 citations

5-HT1A receptor agonists: recent developments and controversial issues

1995 • 463 citations

Modification of 5‐HT neuron properties by sustained administration of the 5‐HT_1A agonist gepirone: Electrophysiological studies in the rat brain

1987 • 429 citations

A Comparative Review On Aggression Konrad Lorenz The Territorial Imperative Robert Ardrey

1968 • 406 citations

Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT_1AReceptors

1998 • 333 citations

Serotonin and Hippocampal Neurogenesis

1999 • 331 citations

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

2000 • 320 citations

Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action

1999 • 306 citations

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

1997 • 302 citations

Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.

1998 • 257 citations

Treatment of major depression

1993 • 255 citations

Role of norepinephrine in depression.

2000 • 251 citations

Penetration of Amitriptyline, but Not of Fluoxetine, into Brain is Enhanced in Mice with Blood-Brain Barrier Deficiency Due to Mdr1a P-Glycoprotein Gene Disruption

2000 • 241 citations

The Long-Term Outcome of Depressive Illness

1988 • 234 citations

1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain

1989 • 229 citations

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-httlpr in delusional and nondelusional depression

2001 • 222 citations

Hyperpolarization of serotonergic neurons by serotonin and LSD: Studies in brain slices showing increased K+ conductance

1984 • 221 citations

Role of the medial prefrontal cortex in 5‐HT_1A receptor‐induced inhibition of 5‐HT neuronal activity in the rat

1999 • 210 citations

Effect of Buspirone on Sexual Dysfunction in Depressed Patients Treated With Selective Serotonin Reuptake Inhibitors

1999 • 196 citations

Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression.

1991 • 191 citations

Autoradiographic quantification of serotonin_1A receptors in rat brain following antidepressant drug treatment

1989 • 185 citations

Selective Activation of Postsynaptic 5-HT1A Receptors Induces Rapid Antidepressant Response

1997 • 183 citations

Clinical Effects of the 5-HT1A Partial Agonists in Depression

1990 • 169 citations

A Critical Review of 5-HT Brain Microdialysis and Behavior

1997 • 169 citations

Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration

1988 • 168 citations

Paroxetine and pindolol

1997 • 164 citations

Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist.

1996 • 162 citations

P-glycoprotein as a Drug Target in the Treatment of Multidrug Resistant Cancer

2000 • 159 citations

Mirtazapine Compared With Paroxetine in Major Depression

2000 • 159 citations

Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.

1998 • 159 citations

How Long Should Pindolol Be Associated With Paroxetine to Improve the Antidepressant Response?

1997 • 157 citations

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine

1994 • 156 citations

Relapse of Depression in Primary Care: Rate and Clinical Predictors

1998 • 155 citations

Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus

1987 • 144 citations

Mirtazapine

1998 • 141 citations

Pindolol and Mianserin Augment the Antidepressant Activity of Fluoxetine in Hospitalized Major Depressed Patients, Including Those With Treatment Resistance

1999 • 140 citations

Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.

1990 • 131 citations

The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex

1994 • 127 citations

Effect of Pindolol on Onset of Action of Paroxetine in the Treatment of Major Depression: Intermediate Analysis of a Double-Blind, Placebo-Controlled Trial

1998 • 127 citations

Female Sexual Dysfunction Associated With Antidepressant Administration: A Randomized, Placebo-Controlled Study of Pharmacologic Intervention

2000 • 126 citations

Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression

1996 • 123 citations

Differential Occupancy of Somatodendritic and Postsynaptic 5HT1A Receptors by Pindolol A Dose-Occupancy Study with [11C]WAY 100635 and Positron Emission Tomography in Humans

2001 • 123 citations

Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study

2000 • 121 citations

Faster Onset of Action of Fluvoxamine in Combination With Pindolol in the Treatment of Delusional Depression

1998 • 111 citations

Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.

1994 • 107 citations

Effect of the antidepressant Org 3770 on human sleep

1990 • 107 citations

Serotonin1A Receptor Activation by Flesinoxan in Humans Body Temperature and Neuroendocrine Responses

1995 • 92 citations

Activation of 5-HT<sub>1A</sub> Receptor Subtype in the Paraventricular Nuclei of the Hypothalamus Induces CRH and ACTH Release in the Rat

1992 • 86 citations

Neurochemistry and Neurophysiology of Buspirone and Gepirone

1990 • 85 citations

Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.

1998 • 84 citations

Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine—I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission

1991 • 83 citations

The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial

1999 • 76 citations

β-blocker Binding to Human 5-HT1A Receptors in vivo and in vitro Implications for Antidepressant Therapy

2000 • 76 citations

Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis

1994 • 75 citations

Behavioral studies of serotonin receptor agonists as antidepressant drugs.

1991 • 74 citations

Serotonergic Stimulation of Prolactin and Corticosterone Secretion Is Mediated by Different Pathways from the Mediobasal Hypothalamus

1985 • 71 citations

Gepirone in the Treatment of Major Depression

1990 • 70 citations

Differential Effect of Gepirone on Presynaptic and Postsynaptic Serotonin Receptors

1990 • 70 citations

Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe

1997 • 66 citations

Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/Go proteins in dorsal raphe nucleus

1994 • 64 citations

Treatment of major depression: is improvement enough?

1999 • 61 citations

Serotonin 1A Receptor Activation and Hypothermia in Humans Lack of Evidence for a Presynaptic Mediation

2002 • 60 citations

Treatment of antidepressant nonresponders: augmentation or switch?

1998 • 60 citations

Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo

1993 • 59 citations

Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.

2001 • 59 citations

Characterization of 5-hydroxytryptamine1A properties of flesinoxan: In Vivo electrophysiology and hypothermia study

1995 • 59 citations

Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei

1997 • 58 citations

Alteration of 5‐HT_1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography

1992 • 55 citations

Gepirone Treatment of Atypical Depression

1994 • 53 citations

A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients.

1996 • 50 citations

Serotonin 5-HT1A Agonists

1994 • 49 citations

Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.

1998 • 38 citations

Gepirone, a selective serotonin (5HT1A) partial agonist in the treatment of major depression

1992 • 36 citations

Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants

1998 • 33 citations

Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine—II. Effects of acute administration of 1-PP and long-term adminstration of tandospirone on noradrenergic neurotransmission

1991 • 32 citations

Serotonin 5-HT1A Receptor Agonists as Antidepressants

1998 • 31 citations

A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.

1996 • 28 citations

Pharmacokinetics of Buspirone Extended‐Release Tablets: A Single‐Dose Study

2001 • 27 citations

Are Two Antidepressant Mechanisms Better Than One?

1997 • 24 citations

A Canadian Multicenter Study of Three Fixed Doses of Controlled-Release Ipsapirone in Outpatients With Moderate to Severe Major Depression

1998 • 22 citations

Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment

1991 • 21 citations

Effect of Food on the Bioavailability of Gepirone in Humans

1993 • 14 citations

Gepirone in Depression and Anxiety Disorders

1994 • 11 citations

Pharmacokinetics of Gepirone in Subjects with Normal Renal Function and in Patients with Chronic Renal Dysfunction

2002 • 2 citations

Deleted Work

1955 • 0 citations